Skip to main content
Moderna, Inc. (MRNA)
NASDAQ: MRNA · Real-Time Price · USD
36.94
-0.35 (-0.94%)
At close: Nov 20, 2024, 4:00 PM
36.75
-0.19 (-0.51%)
Pre-market: Nov 21, 2024, 5:50 AM EST

Moderna Revenue

Moderna had revenue of $1.86B in the quarter ending September 30, 2024, with 1.69% growth. This brings the company's revenue in the last twelve months to $5.08B, down -44.29% year-over-year. In the year 2023, Moderna had annual revenue of $6.85B, down -64.45%.

Revenue (ttm)
$5.08B
Revenue Growth
-44.29%
P/S Ratio
2.78
Revenue / Employee
$907,321
Employees
5,600
Market Cap
14.22B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20236.85B-12.42B-64.45%
Dec 31, 202219.26B792.00M4.29%
Dec 31, 202118.47B17.67B2,200.25%
Dec 31, 2020803.00M743.00M1,238.33%
Dec 31, 201960.00M-75.07M-55.58%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Molina Healthcare 37.54B
Tenet Healthcare 20.97B
Baxter International 15.06B
Viatris 15.05B
ICON Public Limited Company 8.31B
Avantor 6.82B
Incyte 4.08B
United Therapeutics 2.76B
Revenue Rankings

MRNA News

More News